CVR number 41842776
Industry 71.1220 Engineering activities and related technical consultancy

JT Medtech Consult ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.0% 1.0% 1.0% 1.0% 1.0%  
Bankruptcy risk  0.0% 0.0% 6.6% 18.9% 10.9%  
Credit score (0-100)  0 0 35 6 21  
Credit rating  N/A N/A BBB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 1,189 -88.5 -12.3  
EBITDA  0.0 0.0 681 -135 -12.3  
EBIT  0.0 0.0 681 -135 -12.3  
Pre-tax profit (PTP)  0.0 0.0 668.7 -139.8 -13.0  
Net earnings  0.0 0.0 519.5 -109.1 -10.3  
Pre-tax profit without non-rec. items  0.0 0.0 669 -140 -13.0  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 768 659 649  
Interest-bearing liabilities  0.0 0.0 209 55.5 0.0  
Balance sheet total (assets)  0.0 0.0 1,050 874 653  
Net Debt  0.0 0.0 -429 -756 -554  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 1,189 -88.5 -12.3  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 86.1%  
Employees  0 0 0 1 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% -100.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 1,050 874 653  
Balance sheet change%  0.0% 0.0% 0.0% -16.7% -25.3%  
Added value  0.0 0.0 681.3 -134.5 -12.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 -1.0 -2.0  

Profitability 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 57.3% 152.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 64.9% -14.0% -1.6%  
ROI %  0.0% 0.0% 69.7% -15.9% -1.8%  
ROE %  0.0% 0.0% 67.7% -15.3% -1.6%  

Solidity 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 0.0% 73.2% 75.4% 99.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -63.0% 562.2% 4,495.0%  
Gearing %  0.0% 0.0% 27.2% 8.4% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 12.1% 4.0% 3.0%  

Liquidity 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.0 3.7 4.1 133.4  
Current Ratio  0.0 0.0 3.7 4.1 133.4  
Cash and cash equivalent  0.0 0.0 638.2 811.7 554.3  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 767.9 658.8 648.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -135 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -135 0  
EBIT / employee  0 0 0 -135 0  
Net earnings / employee  0 0 0 -109 0